Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells
Abstract Background Bladder cancer is the second most common genitourinary malignancy and the eleventh most common cancer worldwide. Dihydroartemisinin (DHA), a first-line antimalarial drug, has been found to have potent antitumor activity. In our previous study, a novel dihydroartemisinin derivativ...
Saved in:
Main Authors: | Linfan Xiao (Author), Cangcang Xu (Author), Peiyu Lin (Author), Lingli Mu (Author), Xiaoping Yang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
by: Cangcang Xu, et al.
Published: (2020) -
Reduction of Mitochondrial Derived Superoxide by Mito-TEMPO Improves Porcine Oocyte Maturation In Vitro
by: Seul-Gi Yang, et al.
Published: (2019) -
Distinct Analgesic Actions of DHA and DHA-Derived Specialized Pro-Resolving Mediators on Post-operative Pain After Bone Fracture in Mice
by: Linlin Zhang, et al.
Published: (2018) -
Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK
by: Jingfei Zheng, et al.
Published: (2021) -
DHA for Optimal Health
by: Barbara Meyer (Ed.)
Published: (2018)